For the first time in decades, we have a new kind of schizophrenia drug

from www.npr.org 4 months ago

Cobenfy emerges as the first antipsychotic drug targeting muscarinic receptors instead of dopamine, presenting a significant shift in schizophrenia treatment paradigm over the last 70 years.
www.npr.orghttps://www.npr.org/2024/10/23/1211483965/science-drug-medication-schizophrenia-cobenfy

The development of Cobenfy came from a serendipitous scientific discovery during a study that was not primarily aimed at schizophrenia, showcasing the unpredictability of medical research.
www.npr.orghttps://www.npr.org/2024/10/23/1211483965/science-drug-medication-schizophrenia-cobenfy

Read at www.npr.org

#schizophrenia #cobenfy #fda-approval #bristol-myers-squibb #muscarinic-receptors

Collection

[

...

]

For the first time in decades, we have a new kind of schizophrenia drugFor the first time in decades, we have a new kind of schizophrenia drug Briefly

For the first time in decades, we have a new kind of schizophrenia drug
For the first time in decades, we have a new kind of schizophrenia drug
Briefly